The data will be presented at the Annual ALS Drug Development Summit, which is focused on identifying transformative ALS targets, seeking translational biomarkers and propelling more clinical.
Brainstorm Cell Therapeutics Announces First Quarter 2024 Financial Results And Provides Corporate Update menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Rx Rundown: Vertex Pharmaceuticals, Bristol Myers Squibb, Novartis and more mmm-online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mmm-online.com Daily Mail and Mail on Sunday newspapers.
NEW YORK, April 11, 2024 /PRNewswire/ BrainStorm Cell Therapeutics Inc. , a leading developer of cellular therapies for neurodegenerative diseases, today announced that it received a notification.
BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn s® Phase 3 Clinical Trial in ALS streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.